KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
Even Birkeland(Haukeland University Hospital), Helga B. Salvesen(Haukeland University Hospital)
Cited by 84
Related Papers
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
|British Journal of Cancer|2012|61